Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Why the weirdest sea level changes on Earth are happening off the coast of Japan - 2Five EU states press for windfall taxes on fossil energy sector
- 3Toyota Reports 2.3% Sales Drop as China Weakness Deepens
- 4She's been a Bond girl and a mutant. Now she's grappling with Hollywood's obsession with 'eternal youth.'
- 5What will the Artemis 2 astronauts eat during their historic moon mission? (video)
- Wolf bites woman in a shopping area in Germany's 2nd-biggest city
- The Tradition of Stone: A Gander at Notable Structures Through the Ages
- Artemis 2 astronaut Victor Glover delivers inspiring Easter message on the way to the moon (video)
- Scientists map of old Mars river basins for the 1st time. These could be great places to search for ancient life
- High Court weighs Assenheim appeal over release of Feldstein interview raw footage
- NASA releases stunning new images captured by the Artemis II moon mission, including 'Earthset' and a solar eclipse from space
- 'No middle ground' for tackling antisemitism after Bondi Beach mass shooting, deputy FM Haskel says
- Russian billionaire says 12-hour days and 6-day workweeks could help save the economy
- Fact Check: Some Bridge Photos Circulating Do NOT Show The Hongqi Bridge That Collapsed In Southwest China Nov. 11, 2025
